Madryn Asset Management Discloses 14.9% Stake in Neuronetics

Ticker: STIM · Form: SC 13D · Filed: Dec 17, 2024 · CIK: 1227636

Neuronetics, Inc. SC 13D Filing Summary
FieldDetail
CompanyNeuronetics, Inc. (STIM)
Form TypeSC 13D
Filed DateDec 17, 2024
Risk Levelmedium
Pages12
Reading Time15 min
Key Dollar Amounts$0.01
Sentimentneutral

Sentiment: neutral

Topics: 13D-filing, significant-stake, healthcare-devices

Related Tickers: STRL

TL;DR

**Madryn now owns 14.9% of NEUR! Big stake.**

AI Summary

On December 17, 2024, Madryn Asset Management, LP, along with its group members, filed a Schedule 13D indicating they collectively beneficially own 10,380,000 shares of Neuronetics, Inc. common stock, representing 14.9% of the outstanding shares. This filing signifies a significant stake in the company, potentially influencing its strategic direction.

Why It Matters

This filing signals a substantial investment by Madryn Asset Management in Neuronetics, Inc., which could lead to increased shareholder activism or strategic changes within the company.

Risk Assessment

Risk Level: medium — A significant stake disclosure can precede activist campaigns or changes in corporate strategy, introducing uncertainty.

Key Numbers

  • 10,380,000 — Shares Owned (Beneficial ownership by Madryn Asset Management and group members.)
  • 14.9% — Ownership Stake (Percentage of Neuronetics, Inc. common stock held.)

Key Players & Entities

  • Madryn Asset Management, LP (company) — Filing entity
  • Neuronetics, Inc. (company) — Subject company
  • 10,380,000 (dollar_amount) — Number of shares beneficially owned
  • 14.9% (dollar_amount) — Percentage of outstanding shares owned
  • December 17, 2024 (date) — Filing date

FAQ

Who are the group members filing this Schedule 13D?

The group members include MADRYN HEALTH ADVISORS GP II, LLC, MADRYN HEALTH ADVISORS II, LP, MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP, MADRYN HEALTH PARTNERS II, LP, MADRYN SELECT ADVISORS GP, LLC, MADRYN SELECT ADVISORS, LP, and MADRYN SELECT OPPORTUNITIES, LP, all acting in concert with Madryn Asset Management, LP.

What is the total number of shares beneficially owned by the filing group?

The filing group beneficially owns a total of 10,380,000 shares of Neuronetics, Inc. common stock.

What percentage of Neuronetics, Inc. does this ownership stake represent?

This ownership stake represents 14.9% of the outstanding shares of Neuronetics, Inc. common stock.

When was this Schedule 13D filing made?

This Schedule 13D filing was made on December 17, 2024.

What is the primary business of Neuronetics, Inc. according to the filing?

Neuronetics, Inc. is classified under Standard Industrial Classification code 3841, which relates to Surgical & Medical Instruments & Apparatus.

Filing Stats: 3,735 words · 15 min read · ~12 pages · Grade level 16.1 · Accepted 2024-12-17 21:15:11

Key Financial Figures

  • $0.01 — me of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securiti

Filing Documents

From the Filing

SC 13D 1 d888051dsc13d.htm SC 13D SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Neuronetics, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 64131A105 (CUSIP Number) Matthew Girandola 330 Madison Avenue Floor 33 New York, NY 10017 (646) 560-5490 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) December 10, 2024 (Date of Event Which Requires Filing of This Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Note : Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See 240.13d-7 for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP NO. 64131A105 13D Page 2 of 16 Pages 1 NAMES OF REPORTING PERSONS MADRYN ASSET MANAGEMENT, LP 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a)(b) 3 SEC USE ONLY 4 SOURCE OF FUNDS OO 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) 6 CITIZENSHIP OR PLACE OF ORGANIZATION AMERICA NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER 0 8 SHARED VOTING POWER 24,237,061 9 SOLE DISPOSITIVE POWER 0 10 SHARED DISPOSITIVE POWER 24,237,061 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 24,237,061 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 43.6% 14 TYPE OF REPORTING PERSON IA CUSIP NO. 64131A105 13D Page 3 of 16 Pages 1 NAMES OF REPORTING PERSONS MADRYN HEALTH PARTNERS II, LP 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a)(b) 3 SEC USE ONLY 4 SOURCE OF FUNDS OO 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) 6 CITIZENSHIP OR PLACE OF ORGANIZATION AMERICA NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER 0 8 SHARED VOTING POWER 1,335,157 9 SOLE DISPOSITIVE POWER 0 10 SHARED DISPOSITIVE POWER 1,335,157 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,335,157 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 2.4% 14 TYPE OF REPORTING PERSON PN CUSIP NO. 64131A105 13D Page 4 of 16 Pages 1 NAMES OF REPORTING PERSONS MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a)(b) 3 SEC USE ONLY 4 SOURCE OF FUNDS OO 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) 6 CITIZENSHIP OR PLACE OF ORGANIZATION CAYMAN ISLANDS NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER 0 8 SHARED VOTING POWER 20,259,096 9 SOLE DISPOSITIVE POWER 0 10 SHARED DISPOSITIVE POWER 20,259,096 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 20,259,096 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 36.4% 14 TYPE OF REPORTING PERSON PN CUSIP NO. 64131A105 13D Page 5 of 16 Pages 1 NAMES OF REPORTING PERSONS MADRYN HEALTH ADVISORS II, LP 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a)(b) 3 SEC USE ONLY 4 SOURCE OF FUNDS OO 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) 6 CITIZENSHIP OR PLACE OF ORGANIZATION AMERICA NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER 0 8 SHARED VOTING POWER 21,594,253 9 SOLE DISPOSITIVE POWER 0 10 SHARED DISPOSITIVE POWER 21,594,253 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 21,594,253 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 38.8% 14 TYPE OF REPORTING PERSON PN CUSIP NO. 64131A105 13D Page 6 of 1

View Full Filing

View this SC 13D filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.